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Abstract
We performed a bivariate analysis on cholesterol and triglyceride levels on data from the
Framingham Heart Study using a new score statistic developed for the detection of potential
pleiotropic, or cluster, genes. Univariate score statistics were also computed for each trait. At a
significance level 0.001, linkage signals were found at markers GATA48B01 on chromosome 1,
GATA21C12 on chromosome 8, and ATA55A11 on chromosome 16 using the bivariate analysis.
At the same significance level, linkage signals were found at markers 036yb8 on chromosome 3 and
GATA3F02 on chromosome 12 using the univariate analysis. A strong linkage signal was also found
at marker GATA112F07 by both the bivariate analysis and the univariate analysis, a marker for
which evidence for linkage had been reported previously in a related study.
Background
Elevated triglyceride and cholesterol levels are two risk
factors for cardiovascular diseases. These risk factors are
often correlated with each other. In order to map the pos-
sible pleiotropic/clustered genes underlying the inherit-
ance of these two traits, we performed a bivariate linkage
analysis using a score statistic developed by Wang [1]. This
score statistic is asymptotically equivalent to the likeli-
hood ratio statistic and is straightforward to compute. We
apply this statistic to data from Cohort 1 and Cohort 2 of
the Framingham Heart Study.
Methods
Data
Participants in Cohort 1 had up to 16 reported cholesterol
levels, and up to 3 reported triglyceride levels. For partici-
pants in Cohort 2, cholesterol and triglyceride levels were
reported up to 5 times. These two cohorts together pro-
vided 22,040 measurements on the cholesterol level and
9,155 measurements on the triglyceride level (including
all repeated measurements on all individuals). Individu-
als who lacked any measurements of cholesterol level or
triglyceride level were excluded. A single linear regression
of cholesterol on age was fit across different individuals
and different measurements. The residuals from the
regression fit were averaged for each individual. This aver-
age was used as the age-adjusted cholesterol level for that
individual. The same method was used to obtain age-
adjusted triglyceride level for each individual. Sib pairs
from the same nuclear family or from different nuclear
families that belonged to the same pedigree were regarded
as biologically unrelated. For the case of univariate traits,
there are reports showing that treating dependent sib pairs
as independent ones does not increase the type I error rate
of the test [2].
All sib pairs in all the pedigrees in Cohort 1 and Cohort 2
were generated, but not all of these sib pairs were used at
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sis Workshop 13 (GAW13) provided identity-by-descent
(IBD) sharing probabilities for some relative pairs
(including sib pairs) at each of the scanned markers. The
IBD sharing probabilities for a sib pair were available only
for some markers. To simplify the programming, we
excluded those markers at which there were less than
1000 sib pairs whose IBD sharing probabilities were avail-
able. Then, for each chromosome, we used only those sib
pairs whose IBD sharing probabilities were available for
all the remaining markers on that chromosome. See Table
1 for a summary of the number of markers excluded and
the number of sib pairs used for each chromosome.
Analysis
The bivariate score statistic is computed based on the
observed phenotypic data on sib pairs. The phenotypic
data of a sib pair can be denoted by a vector of four
(adjusted) measurements – cholesterol levels on sib 1 and
sib 2, and triglyceride levels on sib 1 and sib 2. Let xi  be
the phenotypic data on the ith sib pair and Σ0 be the sam-
ple variance-covariance of xi. As an average of the residu-
als of a regression, the sample mean of cholesterol levels
on sib 1 and sib 2 is 0, so is the sample mean of triglycer-
ide level. Let Σ0 be a 4 × 4 symmetric matrix whose (i,j)
element is denoted by aij. Note that a11  and a33 are the
variances of the cholesterol and triglyceride levels, respec-
tively, of the first sib in the pairs. Similarly, a22 and a44 are
the variances of the cholesterol and triglyceride levels of
the second sib in the sib pairs. The off-diagonal terms rep-
resent covariances: a13 = a31 is the covariance between cho-
lesterol and triglycerides for the first sib in the sib pairs,
and a24 = a42 is the covariance for the second sib in the sib
pairs. Since the sib-sib relationship in a sib pair is sym-
metric, we expect that a11 ≈ a22, a33 ≈ a44 and a13 ≈ a24
when the sample size is large. Alternatively, we can also
use the (adjusted) measurements on cholesterol and trig-
lycerides on all sibs (do not distinguish sib 1 from sib 2)
in calculating the entries of Σ0. Then there would be a11 =
a22, a33 = a44, and a13 = a24. Since the sample size is fairly
large, we expect both methods give similar Σ0.
Define
wi = (wi1, wi2, wi3, wi4)t = ∑0-1 xi
and
zi = wi1wi2a11 + (wi1wi3 + wi2wi4)a13 + wi3wi4a33.
Denote the proportion of alleles that are shared IBD by
the ith sib pair by πi. Let  and  be the sample means of
{πi} and {zi}, respectively. Define
Table 1: Number of markers available and analyzed on each chromosome
Chr Markers Provided Markers Analyzed Sib PairsA
1 32 30 965
2 30 28 981
3 27 27 380
4 21 21 1215
5 26 24 719
6 23 19 1187
7 22 20 1245
8 19 19 1298
9 19 17 401
10 22 20 970
11 17 15 788
12 19 18 1178
13 12 11 1524
14 17 14 1292
15 13 12 1318
16 14 14 1218
17 16 15 1284
18 15 14 1291
19 11 10 1426
20 11 10 1515
21 6 6 1798
22 7 6 1843
AThe sample size is the same for all markers on the same chromosome.
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tive locus is not linked to any trait locus, the expectation
of b is 0 and its variance is Var(b) = N s2πs2z, where s2π and
s2z are the sample variances of {πi} and {zi}, respectively.
The score statistic S for the bivariate phenotypes is defined
by S = b2/Var(b) if b > 0; S = 0 otherwise. When the puta-
tive locus is not linked to any quantitative trait loci (QTL),
the asymptotic distribution of this one-sided tests statistic,
S, is 0.5 χ20 + 0.5 χ21 [1]. The score statistic S is a special
case described by Wang [1] – the locus specific variances
and covariance for the two traits are assumed to be pro-
portional to their total variances and covariance.
Results
The score statistic S was calculated for every screened
marker. In addition, the univariate score statistic of Wang
and Huang [3] was also calculated for cholesterol level
and triglyceride level separately. For sib-pair data, the type
of data used in our analyses, this univariate score statistic
is equivalent to other methods [4,5]. The p-values of these
three score statistics (one for the bivariate phenotypes,
one for each of the two univariate phenotypes) at each
marker location are plotted in Figure 1. Markers with p-
values less than the significance level of α = 0.005 are
shown in Table 2.
At the significance level 0.005, 10 markers were identified
by the bivariate score statistic: 2 each from chromosome 1
(at 212 cM and 233 cM) and 7 (at 128 cM and 155 cM),
and 1 each from chromosome 3 (at 112 cM), 4 (at 105
cM), 5 (at 19 cM), 6 (at 166 cM), 8 (at 140 cM), and 16
(at 64 cM). Five out of the 10 markers were also identified
by the univariate score statistic for the adjusted triglycer-
ide level. They were the two on chromosome 1, one on
chromosome 7 (at 155 cM), one on chromosome 8, and
one on chromosome 16. None of the 10 markers were
identified by the univariate score statistic for the age-
adjusted cholesterol level. The results seem to suggest that
there were large overlaps of linkage signals between the
bivariate score statistic and the univariate score statistic for
the age-adjusted triglyceride level. There were no overlaps
of linkage signals between the bivariate score statistic and
the univariate score statistic for the age-adjusted choles-
terol level. There were 5 markers that were identified by
the bivariate score statistic, but not identified by any of the
univariate score statistics. There were 3 markers whose p-
values were below 0.001: one on chromosome 1 at 212
cM, one on chromosome 8 at 140 cM, and the other on
chromosome 16 at 64 cM. The regions suggested by these
3 markers may be investigated in future genotyping and
analysis.
Discussion
We performed a bivariate analysis of cholesterol and trig-
lyceride levels on sib-pair data from the Framingham
Heart Study using a method recently developed by Wang
[1]. This method is asymptotically equivalent to the like-
lihood ratio statistic, but is straightforward to calculate.
We also calculated the univariate score statistics for cho-
lesterol and triglyceride levels separately. Five markers
were identified by both the bivariate score statistic and the
univariate score statistic for the adjusted triglyceride level,
while the results of the bivariate score statistics had no
overlap with the univariate score statistic for the age
adjusted cholesterol levels.
The method in Wang [1] is general enough to handle gen-
eral pedigrees, but we only applied it to sib pairs that were
extracted from general pedigrees. This is because the pro-
gramming for sib pairs is relatively easy and was feasible
given the time constraint for GAW13. Some linkage infor-
mation may have lost due to the fact that dependent sib
pairs were treated as independent sib pairs, but the type I
error rate of the test statistic is expected to be valid.
In a related study, Shearman et al. [6] used the ratio of trig-
lyceride level to high-density lipoprotein cholesterol level
as the phenotype of interest. Linkage evidence was
reported at marker GATA112F07 (155 cM on chromo-
some 7), a marker that resulted in a p-value 0.0020 for the
bivariate score statistic used in the current report. These
authors reported a LOD score 1.5 at 70 cM on chromo-
some 16 with multipoint mapping. We used single-point
IBD sharing probabilities with the bivariate score statistic
and obtained a significant linkage signal (p = 0.0001) for
marker ATA55A11 (64 cM on chromosome 16), 6 cM
away from the locus they identified. Other markers in
Table 2 that have small p-values for the bivariate or uni-
variate score statistics but that did not show evidence for
linkage in Shearman et al. [6] include GATA48B01,
036yb8, GATA21C12, and GATA3F02.
One caveat about bivariate analyses is that they are not
always more powerful than univariate analyses. Theoreti-
cal [7] and simulation studies [1,8,9] demonstrate that
when the polygenic correlation is in the same direction as
the major gene correlation, a bivariate analysis may have
lower power than a univariate analysis.
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1 Gata48B01 212 11.029(.0004) 9.141(.0013)
1 GATA87F04 233 8.618(.0017) 7.602(.0029)
3 3PTEL25 1 8.358(.0019)
3 036yb8 37 10.445(.0006)
3 GATA128C02 112 6.799(.0046)
4 GATA24H01 78 6.670(.0049)
4 ATA2A03 93 7.665(.0028)
4 GATA2F11 105 7.534(.0030)
4 ATA26B08 130 7.159(.0037)
5 GATA2A04 19 7.119(.0038)
5 GATA2H09 139 7.682(.0028)
6 242zg5 166 7.776(.0026)
7 GGAA6D03 128 7.036(.0040)
7 GATA112F07 155 8.274(.0020) 8.410(.0019)
8 GATA21C12 140 10.474(.0006) 7.603(.0029)
12 GATA49D12 18 7.695(.0028)
12 GATA3F02 81 9.674(.0009)
14 GATA4B04 44 8.648(.0016)
16 ATA55A11 64 13.489(.0001) 11.049(.0004)
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